http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3696931

Outgoing Links

Predicate Object
contentType Comparative Study|Journal Article|Research Support, N.I.H., Extramural|Research Support, Non-U.S. Gov't|Research Support, U.S. Gov't, P.H.S.
endingPage 342
issn 1524-4539
0009-7322
issueIdentifier 3
pageRange 334-342
publicationName Circulation
startingPage 334
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_77e2488754b2b37f99f84e3d30d28ece
isSupportedBy http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c9de9676b92145d8f0214d3ac68015f1
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7d19d63f3c35cca53833d72ff5067c5a
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_21dc55c22b1c4ab1ef1f08e6e03636d2
bibliographicCitation Egan KM, Wang M, Fries S, Lucitt MB, Zukas AM, Puré E, Lawson JA, FitzGerald GA. Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism. Circulation. 2005 Jan 25;111(3):334–42. doi: 10.1161/01.cir.0000153386.95356.78. PMID: 15655126.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-0532-6312
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_84a34fbb79810967c2f6732750c06571
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8f5a34f92d6def2404ef023a4674e6e3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e9ae4f1e89ebe415f93f923cd736b25d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_75847d4e1a61e94778a2ff0c8d324571
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec626e7b16def38153bfab4768535069
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_176bb57d7337ea2853e48f9b566769f9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c54667e306dbe751a3dfe5bcd47b908c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7d1bc46cc1dfb01d1e32e8b85a197746
date 2005-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/15655126
https://doi.org/10.1161/01.cir.0000153386.95356.78
isPartOf https://portal.issn.org/resource/ISSN/1524-4539
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2979
https://portal.issn.org/resource/ISSN/0009-7322
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Cyclooxygenases, thromboxane, and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism
discusses http://id.nlm.nih.gov/mesh/M0014459
http://id.nlm.nih.gov/mesh/M0258705
http://id.nlm.nih.gov/mesh/M0021438
http://id.nlm.nih.gov/mesh/M0260351
http://id.nlm.nih.gov/mesh/M0268475
http://id.nlm.nih.gov/mesh/M0480929
http://id.nlm.nih.gov/mesh/M0006335
http://id.nlm.nih.gov/mesh/M0017803
http://id.nlm.nih.gov/mesh/M0017759
http://id.nlm.nih.gov/mesh/M0025664
http://id.nlm.nih.gov/mesh/M0290640
http://id.nlm.nih.gov/mesh/M0013341
http://id.nlm.nih.gov/mesh/M0026518
http://id.nlm.nih.gov/mesh/M0446346
http://id.nlm.nih.gov/mesh/M0008898
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D016861Q000494
http://id.nlm.nih.gov/mesh/D011451Q000378
http://id.nlm.nih.gov/mesh/D017482Q000037
http://id.nlm.nih.gov/mesh/D001161Q000517
hasSubjectTerm http://id.nlm.nih.gov/mesh/D011422Q000494
http://id.nlm.nih.gov/mesh/D001011Q000473
http://id.nlm.nih.gov/mesh/D051379
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D005663Q000494
http://id.nlm.nih.gov/mesh/D051545
http://id.nlm.nih.gov/mesh/D051546
http://id.nlm.nih.gov/mesh/D013928Q000378
http://id.nlm.nih.gov/mesh/D008565
http://id.nlm.nih.gov/mesh/D052246
http://id.nlm.nih.gov/mesh/D001161Q000378
http://id.nlm.nih.gov/mesh/D004347
http://id.nlm.nih.gov/mesh/D001161Q000473
http://id.nlm.nih.gov/mesh/D009281Q000494
http://id.nlm.nih.gov/mesh/D004041Q000008
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282411
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280360
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d22ef8d03375d89409872210d728cfc0
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_25e7482d087cb6429609f07a507aa159
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7428
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_00d2609a21ed191377e6db59f9602b29
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_37f213562115253889cdfb9d2fc3388c
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6145931
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6438342
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10898
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9938840
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3715
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_31e4f22b0420d188eb4ce1951b45ede2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114873

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129205760
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21390
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128194172

Total number of triples: 85.